PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Artificial Intelligence as an Aid to Pharmacovigilance

Pharm Exec Brand of the Year: A Retrospective

FDA Closer to a Digital Health Unit

Advertisement
Top Story
Gottlieb’s Multiple FDA Challenges
Now that the Senate has confirmed Scott Gottlieb as FDA commissioner, Jill Wechsler outlines a few of the issues awaiting the agency's new leader
/Read more/
Advertisement
DCAT Week: Business Development—Networking—Education
DCAT Week is the premier global event for the business of pharmaceutical development and manufacturing (March 20-23 in New York City). Organized by the Drug, Chemical & Associated Technologies Association, its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities. Learn more
ADVERTISEMENT
 
Special Feature
Pharm Exec’s Brands of the Year 2017
In its 11th annual feature, Pharm Exec breaks from the norm to profile five products that are currently shining the spotlight on critical and highly debated aspects of healthcare and R&D
/Read more/
Advertisement
Accelerate the launch of your pharma product, while also easing financial and administrative burdens with 3PL Title Model.
Learn more
Event
HBA Woman of the Year Shares Success Secrets
Among those honored at the Healthcare Businesswomen's Association Women of the Year awards luncheon, Bahija Jallal's story is one of courage and resilience, writes Michelle Maskaly
/Read more/
Advertisement
2017 Real-World Evidence Benchmark Survey
Deloitte's 2017 Real-World Evidence Benchmark Survey shows that life sciences companies are making some progress in using RWE but still have opportunities to expand applications across the value chain, consider new channels to access RWD, and improve their overall capabilities.
Explore this research Today!
Call for Nominations
Pharm Exec's Emerging Pharma Leaders 2017 — Nominate Here
Read here for details of how to nominate a colleague — or yourself — for Pharm Exec's annual Emerging Pharma Leaders feature
/Read more/
Advertisement
Run the Trial You Want: Transform clinical trials with better data collection
This paper will focus on the challenges with collecting data required for a protocol and best practices to address them. Learn how to meet the demands of modern trials with modern, cloud based electronic data capture (EDC) systems that enable you to run the trial you want. Sponsored by Veeva Systems
Read it Today!
Calendar
/ May 21–24: 6th Pharmaceutical Sciences World Congress 2017 /
Stockholm, Sweden
/ June 6–7: Pharmaceutical Compliance Congress Canada /
Toronto, CA
/ June 27–28: Publication and Clinical Trial Transparency /
Barcelona, Spain
/ September 14–15: Risk Based Global Monitoring 2017 /
Barcelona, Spain
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
Advertisement
How Cents-Per-Mile Programs Jeopardize Your Bottom Line
Do you reimburse your mobile employees based on a cents-per-mile rate? This type of mileage reimbursement program can cost your company, put you at risk of a class-action lawsuit, and incentivize unproductive driving behavior.
Learn how to protect your business.
Advertisement
Precision Medicine in Immuno-Oncology
The ongoing advances in cancer immunotherapy together with precision medicine may promise a bright future for patients. Learn about the two most common biomarkers in clinical trials that are critical for the drug development process. Sponsored by Covance
Learn more
Strategy
Launch for Long-Term Success
Is a fast launch the only path to a high-value product? Surprisingly, the answer is no. A study by The Boston Consulting Group looks at why a pharma brand's early sales are not a trusted predictor for total lifetime value—it's about driving waves of growth
/Read more/
Advertisement
Talking the Patients' Language – the importance of effective, patient-centered engagement
Live Webinar: Tuesday, June 6 at 8:00am EDT
Register now
Industry update
//Caris Life Sciences (Irving, TX) appointed John Marshall, M.D., as Chief Medical Officer.//Judit H. Nyirady, M.D., M.B.A. joined LEO Pharma (Madison, NJ) as Vice President of Medical Strategy & Scientific Affairs. //Boston Biomedical (Cambridge, MA) appointed Patricia S. Andrews as Chief Executive Officer. //Nativis (Seattle, WA) appointed Dr. Donna Morgan Murray as Chief Regulatory Officer.//
Advertisement
Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
On Demand
Learn more
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com